Back to search results

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Diffuse Cutaneous Systemic Sclerosis · Rheumatoid Arthritis (RA) · Systemic Sclerosis (SSc) · Autoimmune Rheumatologic Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

    Contact: Study coordinator (Benjamin Fisher) · ClinicalResearchFacilityEnquiries@uhb.nhs.uk · 0121 627 8314
    Contact: Principal Investigator (Benjamin Fisher)

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Contact: Study coordinator (Francesco Del Gado) · leedscrf@nhs.net · 0113 392 4444
    Contact: Principal Investigator (Francesco Del Galdo)

  • Guy's & St Thomas NHS Foundation Trust, London, United Kingdom

    Contact: Study coordinator (Andrew Cope) · gstt.crfadmin@nhs.net · 020 7188 7188
    Contact: Principal Investigator (Andrew Cope)

  • Royal Free London NHS Foundation Trust, London, United Kingdom

    Contact: Study coordinator (Voon Ong) · rf.crf@nhs.net · 020 7472 6201
    Contact: Principal Investigator (Voon Ong)

  • Newcastle Upon Tyne NHS Foundation Trust, Newcastle, United Kingdom

    Contact: Study coordinator (John Isaacs) · crf.admin@newcastle.ac.uk · 0191 282 4444
    Contact: Principal Investigator (John Isaacs)

  • University of Oxford - The Kennedy Institute, Oxford, United Kingdom

    Contact: Study coordinator (Chris Buckley) · emcrf@ouh.nhs.uk · 01865 612 600
    Contact: Principal Investigator (Chris Buckley)
View source on ClinicalTrials.gov(opens in a new tab)